Arch Chemicals has signed a definitive agreement to acquire Avecia’s biocides business, which is comprised of a protection and hygiene business and a pool and spa business, for approximately $210 million. The transaction is expected to close near the end of the first quarter.
“These two businesses strengthen the core of our portfolio,” said Michael E. Campbell, Arch Chemical’s chairman, president and CEO. “The protection and hygiene business provides the opportunity for Arch to expand our product offerings, enter into health and hygiene customer segment and broaden our global toxicology and environmental fate capabilities.”
The two businesses combined employ approximately 290 people worldwide and had combined sales of approximately $137 million in 2003. Their primary manufacturing centers are located in the UK, with additional toll manufacturing and customer support capabilities located throughout the world.